Holen Sie sich die Stockscreener-App
3.27
3.54%
-0.12
Handel nachbörslich:
3.21
-0.06
-1.83%
Schlusskurs vom Vortag:
$3.39
Offen:
$3.38
24-Stunden-Volumen:
142.44K
Relative Volume:
1.29
Marktkapitalisierung:
$42.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.20M
KGV:
-0.073
EPS:
-44.82
Netto-Cashflow:
$-50.66M
1W Leistung:
-8.40%
1M Leistung:
+20.66%
6M Leistung:
+30.80%
1J Leistung:
-79.93%
1-Tages-Spanne:
$3.25
$3.50
1-Wochen-Bereich:
$3.16
$3.625
52-Wochen-Spanne:
$1.70
$17.74
Onkure Therapeutics Inc Stock (OKUR) Company Profile
Firmenname
Onkure Therapeutics Inc
Sektor
Branche
Telefon
(720) 307-2892
Adresse
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Vergleichen Sie OKUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OKUR
Onkure Therapeutics Inc
|
3.27 | 45.87M | 0 | -70.20M | -50.66M | -44.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-30 | Eingeleitet | Evercore ISI | Outperform |
| 2024-12-05 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-10 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-15 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | Herabstufung | Jefferies | Buy → Hold |
| 2023-12-15 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-12-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | Eingeleitet | William Blair | Outperform |
| 2023-08-28 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-07-03 | Eingeleitet | BofA Securities | Buy |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-27 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2021-05-04 | Eingeleitet | Jefferies | Buy |
| 2021-05-04 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Onkure Therapeutics Inc Aktie (OKUR) Neueste Nachrichten
Is it time to cut losses on OnKure Therapeutics Inc.Portfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Custom watchlist performance reports with OnKure Therapeutics Inc.Quarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
OnKure Therapeutics Inc.’s volatility index tracking explainedGold Moves & Short-Term Trading Alerts - newser.com
Will OnKure Therapeutics Inc. stock remain a Wall Street favoriteWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
What valuation multiples suggest for OnKure Therapeutics Inc. stockWeekly Market Outlook & Expert Curated Trade Setups - newser.com
Will OnKure Therapeutics Inc. stock continue upward momentumIPO Watch & Entry Point Strategy Guides - newser.com
How to read the order book for OnKure Therapeutics Inc.2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
What momentum shifts mean for OnKure Therapeutics Inc.Earnings Recap Summary & Growth-Oriented Investment Plans - newser.com
Analyzing drawdowns of OnKure Therapeutics Inc. with statistical toolsIPO Watch & Target Return Focused Stock Picks - newser.com
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
How rising interest rates impact OnKure Therapeutics Inc. stockJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Is OnKure Therapeutics Inc. stock ready for a breakoutJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Can you recover from losses in OnKure Therapeutics Inc.2025 Pullback Review & Risk Controlled Daily Plans - newser.com
How OnKure Therapeutics Inc. stock compares to market leadersWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Is OnKure Therapeutics Inc. stock affected by interest rate hikesExit Point & Safe Entry Zone Identification - fcp.pa.gov.br
Will OnKure Therapeutics Inc. stock continue dividend increases2025 Growth vs Value & Detailed Earnings Play Strategies - fcp.pa.gov.br
Can OnKure Therapeutics Inc. stock maintain growth trajectory2025 Dividend Review & Daily Oversold Bounce Ideas - fcp.pa.gov.br
How strong is OnKure Therapeutics Inc. stock revenue growth2025 Earnings Impact & Proven Capital Preservation Tips - fcp.pa.gov.br
Why hedge funds are buying OnKure Therapeutics Inc. stockJuly 2025 Price Swings & Comprehensive Market Scan Reports - fcp.pa.gov.br
What Analyst Models Predict for Ravinder Heights Limiteds 5Year GrowthValue Traps to Avoid & Big Gains Low Budget - earlytimes.in
Finanzdaten der Onkure Therapeutics Inc-Aktie (OKUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):